1. Home
  2. BNTC vs QNBC Comparison

BNTC vs QNBC Comparison

Compare BNTC & QNBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Benitec Biopharma Inc.

BNTC

Benitec Biopharma Inc.

HOLD

Current Price

$8.75

Market Cap

307.7M

Sector

Health Care

ML Signal

HOLD

Logo QNB Corp. Common Stock

QNBC

QNB Corp. Common Stock

N/A

Current Price

$46.00

Market Cap

281.3M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
BNTC
QNBC
Founded
1995
1877
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
307.7M
281.3M
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
BNTC
QNBC
Price
$8.75
$46.00
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
★ $24.33
N/A
AVG Volume (30 Days)
★ 174.2K
23.7K
Earning Date
11-13-2026
10-30-2026
Dividend Yield
N/A
★ 3.40%
EPS Growth
6.67
★ 21.15
EPS
N/A
★ 1.32
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$34.73
Revenue Growth
N/A
N/A
52 Week Low
$8.00
$44.75
52 Week High
$16.76
$46.60

Technical Indicators

Market Signals
Indicator
BNTC
QNBC
Relative Strength Index (RSI) 42.16 55.58
Support Level $8.52 $45.60
Resistance Level $14.09 $46.60
Average True Range (ATR) 0.58 0.49
MACD 0.12 -0.01
Stochastic Oscillator 51.76 53.33

Price Performance

Historical Comparison
BNTC
QNBC

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on advancing novel genetic medicines. Its technology could provide a one-shot cure for a wide range of diseases that require strict, ongoing treatment regimens or have no effective treatment or only palliative care options. The Company is developing a silence-and-replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life-threatening genetic disorder. The company has a single operating segment, which is the business of discovery and development of therapeutic agents for the treatment of genetic disorders.

About QNBC QNB Corp. Common Stock

QNB Corp is a bank holding company based in the United States. It operates through its wholly-owned subsidiary, which engages in the general commercial banking business and offers a full range of banking services to its customers. Its business activities involve attracting deposits and using funds in making commercial loans, residential mortgage loans, consumer loans, and purchasing investment securities. The loan portfolio includes commercial loans, such as commercial and industrial, construction, and loans secured by commercial real estate and residential real estate, and retail loans, including home equity loans and lines, and consumer loans. It generates revenue from net interest income.

Share on Social Networks: